{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:38Z","timestamp":1786997918466,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vacunas"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.vacun.2022.06.007","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T08:57:02Z","timestamp":1662454622000},"page":"245-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The global reemergence of human Monkeypox; is mass vaccination essential?"],"prefix":"10.1016","volume":"23","author":[{"given":"Ali Beheshti","family":"Namdar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Keikha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vacun.2022.06.007_bb0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1699-0463.1959.tb00328.x","article-title":"A pox-like disease in cynomolgus monkeys","volume":"46","author":"Magnus","year":"1959","journal-title":"Acta Pathol Microbiol Scand"},{"key":"10.1016\/j.vacun.2022.06.007_bb0010","first-page":"642","article-title":"Update: multistate outbreak of monkeypox\u2014Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003","volume":"52","author":"Centers for Disease Control and Prevention (CDC)","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vacun.2022.06.007_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","author":"Adler","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"14","key":"10.1016\/j.vacun.2022.06.007_bb0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.15585\/mmwr.mm7114a1","article-title":"Monkeypox in a traveler returning from Nigeria\u2014Dallas, Texas, July 2021","volume":"71","author":"Rao","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.vacun.2022.06.007_bb0025","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3201\/eid2704.203569","article-title":"Reemergence of human monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017\u20132020","volume":"27","author":"Nguyen","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.vacun.2022.06.007_bb0030","doi-asserted-by":"crossref","first-page":"306","DOI":"10.15585\/mmwr.mm6710a5","article-title":"Emergence of monkeypox\u2014west and central Africa, 1970\u20132017","volume":"67","author":"Durski","year":"2018","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vacun.2022.06.007_bb0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fpubh.2018.00241","article-title":"Emergence of monkeypox as the most important orthopoxvirus infection in humans","volume":"6","author":"Sklenovska","year":"2018","journal-title":"Front Public Health"},{"issue":"8","key":"10.1016\/j.vacun.2022.06.007_bb0040","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S1473-3099(19)30294-4","article-title":"Outbreak of human monkeypox in Nigeria in 2017\u201318: a clinical and epidemiological report","volume":"19","author":"Yinka-Ogunleye","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"7912","key":"10.1016\/j.vacun.2022.06.007_bb0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/d41586-022-01421-8","article-title":"Monkeypox goes global: why scientists are on alert","volume":"606","author":"Kozlov","year":"2022","journal-title":"Nature."},{"issue":"8","key":"10.1016\/j.vacun.2022.06.007_bb0050","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/infdis\/jiaa559","article-title":"Exportation of monkeypox virus from the African continent","volume":"225","author":"Mauldin","year":"2022","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vacun.2022.06.007_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox\u2014a potential threat? A systematic review","volume":"16","author":"Bunge","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vacun.2022.06.007_bb0060","unstructured":"WHO. 2018 Annual review of diseases prioritized under the Research and Development Blueprint Informal consultation 6\u20137 February 2018 Geneva, Switzerland. Available at: 2018-annual-review-of-diseases-prioritized-under-the-research-and-development-blueprint.pdf(who.int)."},{"issue":"3","key":"10.1016\/j.vacun.2022.06.007_bb0065","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ije\/17.3.643","article-title":"The transmission potential of monkeypox virus in human populations","volume":"17","author":"Fine","year":"1988","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.1016\/j.vacun.2022.06.007_bb0070","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3201\/eid2805.220292","article-title":"Imported monkeypox from international traveler, Maryland, USA, 2021","volume":"28","author":"Costello","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.vacun.2022.06.007_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007791","article-title":"A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy","volume":"13","author":"Beer","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vacun.2022.06.007_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","author":"Adler","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vacun.2022.06.007_bb0085","article-title":"Monkeypox: healthcare workers will be offered smallpox vaccine as UK buys 20 000 doses","volume":"377","author":"Mahase","year":"2022","journal-title":"BMJ."},{"key":"10.1016\/j.vacun.2022.06.007_bb0090","article-title":"Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the advisory committee on immunization practices\u2014United States, 2022","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vacun.2022.06.007_bb0095","author":"Available"}],"container-title":["Vacunas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157698872200070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157698872200070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:37:48Z","timestamp":1761622668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157698872200070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S157698872200070X"],"URL":"https:\/\/doi.org\/10.1016\/j.vacun.2022.06.007","relation":{},"ISSN":["1576-9887"],"issn-type":[{"value":"1576-9887","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The global reemergence of human Monkeypox; is mass vaccination essential?","name":"articletitle","label":"Article Title"},{"value":"Vacunas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vacun.2022.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}